Article Information
History
- April 18, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 18, 2020 - 01:12).
- Version 2 (April 21, 2020 - 05:27).
- Version 3 (May 1, 2020 - 01:16).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sean Cuddy1,2,#,
- Austin R. Schinlever1,#,
- Sara Dochnal1,
- Jon Suzich1,
- Parijat Kundu1,
- Taylor K. Downs3,
- Mina Farah1,
- Bimal Desai3,
- Chris Boutell4 and
- Anna R. Cliffe1,*
- 1Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, 22908.
- 2Neuroscience Graduate Program, University of Virginia, Charlottesville, VA, 22908
- 3Department of Pharmacology, University of Virginia, Charlottesville, VA, 22908.
- 4MRC-University of Glasgow Centre for Virus Research (CVR), Garscube Campus, Glasgow, Scotland, United Kingdom
- ↵*Correspondence to Anna R. Cliffe, cliffe{at}virginia.edu
↵# Denotes equal contribution